• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012 - Product Image

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012

  • ID: 2366135
  • December 2012
  • Region: Global
  • 139 pages
  • GlobalData

Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012

Summary

Our clinical trial report, “Kidney Cancer (Renal Cell Cancer) Global Clinical Trials Review, H2, 2012" provides data on the Kidney Cancer (Renal Cell Cancer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kidney Cancer (Renal Cell Cancer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kidney Cancer (Renal Cell Cancer). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and READ MORE >

Note: Product cover images may vary from those shown

List of Tables
List of Figures
Introduction
Kidney Cancer (Renal Cell Cancer)
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Kidney Cancer (Renal Cell Cancer)
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Bayer AG
Clinical Trial Overview of Bayer AG
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Novartis AG
Clinical Trial Overview of Novartis AG
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
AVEO Pharmaceuticals, Inc.
Clinical Trial Overview of AVEO Pharmaceuticals, Inc.
Argos Therapeutics, Inc.
Clinical Trial Overview of Argos Therapeutics, Inc.
Pierre Fabre Medicament
Clinical Trial Overview of Pierre Fabre Medicament
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Agenus, Inc.
Clinical Trial Overview of Agenus, Inc.
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
Seattle Genetics, Inc.
Clinical Trial Overview of Seattle Genetics, Inc.
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Oxford BioMedica plc
Clinical Trial Overview of Oxford BioMedica plc
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Novartis Pharmaceuticals Corporation
Clinical Trial Overview of Novartis Pharmaceuticals Corporation
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
The University of Chicago
Clinical Trial Overview of The University of Chicago
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Beth Israel Deaconess Medical Center
Clinical Trial Overview of Beth Israel Deaconess Medical Center
Radboud University
Clinical Trial Overview of Radboud University
Barbara Ann Karmanos Cancer Institute
Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
Wake Forest University
Clinical Trial Overview of Wake Forest University
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Masonic Cancer Center
Clinical Trial Overview of Masonic Cancer Center
University Health Network
Clinical Trial Overview of University Health Network
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
Duke University
Clinical Trial Overview of Duke University
The Methodist Hospital System
Clinical Trial Overview of The Methodist Hospital System
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Suspended Clinical Trials, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Argos Therapeutics, Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pierre Fabre Medicament, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Agenus, Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oxford BioMedica plc, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Methodist Hospital System, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-

List of Figures
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, G7 Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, E7 Countries (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Kidney Cancer (Renal Cell Cancer) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos